Senti Biosciences, Inc. (SNTI)

Senti Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	48.28	35.93	57.62	56.03	30.54
Short-Term Investments	0.34	0.04	42.15	1.16	0.03
Cash & Short-Term Investments	48.61	35.97	99.77	57.19	30.56
Cash Growth	35.15%	-63.95%	74.45%	87.13%	71.42%
Accounts Receivable	0.16	0.11	0.63	0.48	0.32
Other Receivables	1.65	17.59	-	-	-
Receivables	1.81	17.7	0.63	0.48	0.32
Prepaid Expenses	7.96	17.33	1.87	0.8	-
Other Current Assets	0.58	0.2	0.31	1.72	0.83
Total Current Assets	58.96	71.2	102.58	60.19	31.71
Property, Plant & Equipment	35.24	41.61	69.78	33.08	16.14
Other Long-Term Assets	3.64	6.67	8.43	3.43	0.5
Total Assets	97.84	119.48	180.79	96.7	48.35
Accounts Payable	1.45	1.25	1.37	5.19	0.91
Accrued Expenses	6.27	5.93	12.58	5.33	2
Current Portion of Leases	4.75	4.13	1.99	1.74	1.52
Current Unearned Revenue	0.66	0.99	0.8	1.66	-
Other Current Liabilities	0.01	0.38	1.32	0.63	0.44
Total Current Liabilities	13.15	12.67	18.05	14.54	4.87
Long-Term Leases	28.89	33.54	35.1	20.99	12.53
Long-Term Unearned Revenue	-	-	-	0.18	-
Other Long-Term Liabilities	5.05	6.36	0.37	0.62	-
Total Liabilities	47.09	52.57	53.53	36.33	17.4
Common Stock	0	0	0	-	0
Additional Paid-In Capital	322.78	311.26	300.54	3.62	1.04
Retained Earnings	-297.13	-244.34	-173.29	-115.08	-59.76
Comprehensive Income & Other	-	-	0	-	-
Total Common Equity	25.65	66.91	127.26	-111.46	-58.71
Shareholders' Equity	50.76	66.91	127.26	60.38	30.95
Total Liabilities & Equity	97.84	119.48	180.79	96.7	48.35
Total Debt	33.64	37.67	37.09	22.73	14.05
Net Cash (Debt)	14.97	-1.7	62.68	34.46	16.51
Net Cash Growth	-	-	81.89%	108.68%	446.97%
Net Cash Per Share	3.26	-0.38	24.01	118.33	11.91
Filing Date Shares Outstanding	26	4.57	4.42	1.52	1.45
Total Common Shares Outstanding	4.83	4.57	4.41	1.52	1.45
Working Capital	45.82	58.53	84.53	45.65	26.84
Book Value Per Share	5.31	14.64	28.88	-73.38	-40.48
Tangible Book Value	25.65	66.91	127.26	-111.46	-58.71
Tangible Book Value Per Share	5.31	14.64	28.88	-73.38	-40.48
Machinery	8.18	8.87	8.56	5.54	3.91
Construction In Progress	-	-	43.89	8.05	0.23
Leasehold Improvements	22.66	22.65	1.87	0.43	0.16

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q